|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
ALRN
|
Aileron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PSTX
|
Poseida Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TCRR
|
TCR2 Therapeutics Inc.
|
US
|
NASDAQ
|
|
TGTX
|
TG Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HMDCF
|
Hutchison China Ltd
|
US
|
OTC
|
|
GMAB
|
Genmab A/S
|
DK
|
CO
|
|
0013
|
HUTCHMED China Ltd
|
HK
|
HK
|
|
2162
|
Keymed Biosciences Inc
|
HK
|
HK
|
|
2171
|
CARsgen Therapeutics Holdings Ltd
|
HK
|
HK
|
|
6855
|
Ascentage Pharma Grp International
|
HK
|
HK
|
|
AROC
|
AroCell AB
|
SE
|
ST
|
|
SPEX
|
Spexis AG
|
CH
|
SW
|
|
RVU
|
Ryvu Therapeutics SA
|
PL
|
WAR
|
|
ASPHF
|
Ascentage Pharma Group
|
US
|
OTC
|